D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function

  1. Tak Wah Mak1,3,6
  1. 1The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Ontario M5G 2C1, Canada;
  2. 2Department of Neuropathology, Heinrich Heine University, 40225 Düsseldorf, Germany;
  3. 3Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2C1, Canada;
  4. 4La Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA;
  5. 5Agios Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, USA

    Abstract

    Isocitrate dehydrogenase-1 (IDH1) R132 mutations occur in glioma, but their physiological significance is unknown. Here we describe the generation and characterization of brain-specific Idh1 R132H conditional knock-in (KI) mice. Idh1 mutation results in hemorrhage and perinatal lethality. Surprisingly, intracellular reactive oxygen species (ROS) are attenuated in Idh1-KI brain cells despite an apparent increase in the NADP+/NADPH ratio. Idh1-KI cells also show high levels of D-2-hydroxyglutarate (D2HG) that are associated with inhibited prolyl-hydroxylation of hypoxia-inducible transcription factor-1α (Hif1α) and up-regulated Hif1α target gene transcription. Intriguingly, D2HG also blocks prolyl-hydroxylation of collagen, causing a defect in collagen protein maturation. An endoplasmic reticulum (ER) stress response induced by the accumulation of immature collagens may account for the embryonic lethality of these mutants. Importantly, D2HG-mediated impairment of collagen maturation also led to basement membrane (BM) aberrations that could play a part in glioma progression. Our study presents strong in vivo evidence that the D2HG produced by the mutant Idh1 enzyme is responsible for the above effects.

    Keywords

    Footnotes

    • Received June 8, 2012.
    • Accepted July 31, 2012.
    | Table of Contents

    Life Science Alliance